Associations of CKIP-1 and LOX-1 polymorphisms with the risk of type 2 diabetes mellitus with hypertension among Chinese adults

[1] Roth GA(2020)Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study J Am Coll Cardiol 76 2982-3021

[2] Mensah GA(2020)HIV and cardiovascular disease Lancet HIV 7 e279-e293

[3] Johnson CO(2021)The emerging role of metabolism in brain-heart axis: new challenge for the therapy and prevention of Alzheimer disease. May thioredoxin interacting protein (TXNIP) play a role? Biomolecules 11 1652-808

[4] So-Armah K(2020)Modifiable risk factors, cardiovascular disease, and mortality in 155722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study Lancet 395 795-7

[5] Benjamin LA(2023)Prevention and treatment of heart failure from the perspective of hypertension: diagnosis of patients with hypertensive heart failure Rural Med China 30 4-396

[6] Bloomfield GS(2019)Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management Lancet Diabetes Endocrinol 7 385-716

[7] Perrone L(2017)Association between changes in systolic blood pressure and incident diabetes in a community-based cohort study in Korea Hypertens Res 40 710-610

[8] Valente M(2017)Blood pressure control in type 2 diabetic patients Cardiovasc Diabetol 16 3-1653

[9] Yusuf S(2012)Diabetes and hypertension: the bad companions Lancet 380 601-404

[10] Joseph P(2016)Management of hypertension and diabetes mellitus by cardiovascular and endocrine physicians: a China registry J Hypertens 34 1648-156

[1] Roth GA(2020)Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study J Am Coll Cardiol 76 2982-3021

[2] Mensah GA(2020)HIV and cardiovascular disease Lancet HIV 7 e279-e293

[3] Johnson CO(2021)The emerging role of metabolism in brain-heart axis: new challenge for the therapy and prevention of Alzheimer disease. May thioredoxin interacting protein (TXNIP) play a role? Biomolecules 11 1652-808

[4] So-Armah K(2020)Modifiable risk factors, cardiovascular disease, and mortality in 155722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study Lancet 395 795-7

[5] Benjamin LA(2023)Prevention and treatment of heart failure from the perspective of hypertension: diagnosis of patients with hypertensive heart failure Rural Med China 30 4-396

[6] Bloomfield GS(2019)Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management Lancet Diabetes Endocrinol 7 385-716

[7] Perrone L(2017)Association between changes in systolic blood pressure and incident diabetes in a community-based cohort study in Korea Hypertens Res 40 710-610

[8] Valente M(2017)Blood pressure control in type 2 diabetic patients Cardiovasc Diabetol 16 3-1653

[9] Yusuf S(2012)Diabetes and hypertension: the bad companions Lancet 380 601-404

[10] Joseph P(2016)Management of hypertension and diabetes mellitus by cardiovascular and endocrine physicians: a China registry J Hypertens 34 1648-156